QINLOCK (RIPRETINIB) — FDA Approval NDA213973 (DECIPHERA PHARMS)
QINLOCK (RIPRETINIB) — FDA Approval NDA213973 (DECIPHERA PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: QINLOCK; Active ingredients: RIPRETINIB; Application number: NDA213973.
| Brand name | QINLOCK |
|---|---|
| Active ingredients | RIPRETINIB |
| Application number | NDA213973 |
| Sponsor | DECIPHERA PHARMS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20200515 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →